Compare KMDA & ARQQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KMDA | ARQQ |
|---|---|---|
| Founded | 1990 | 2017 |
| Country | Israel | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 385.3M | 422.6M |
| IPO Year | N/A | N/A |
| Metric | KMDA | ARQQ |
|---|---|---|
| Price | $7.93 | $27.10 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $13.00 | ★ $60.00 |
| AVG Volume (30 Days) | 65.4K | ★ 363.7K |
| Earning Date | 11-10-2025 | 12-09-2025 |
| Dividend Yield | ★ 2.54% | N/A |
| EPS Growth | ★ 30.41 | N/A |
| EPS | ★ 0.35 | N/A |
| Revenue | ★ $174,787,000.00 | $530,000.00 |
| Revenue This Year | $14.79 | $1,054.72 |
| Revenue Next Year | $10.74 | $30.00 |
| P/E Ratio | $22.11 | ★ N/A |
| Revenue Growth | ★ 10.36 | N/A |
| 52 Week Low | $5.54 | $11.00 |
| 52 Week High | $9.16 | $62.00 |
| Indicator | KMDA | ARQQ |
|---|---|---|
| Relative Strength Index (RSI) | 73.81 | 51.55 |
| Support Level | $6.92 | $21.43 |
| Resistance Level | $7.17 | $29.20 |
| Average True Range (ATR) | 0.17 | 1.85 |
| MACD | 0.08 | 0.68 |
| Stochastic Oscillator | 88.60 | 73.42 |
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product SKA-Platform. The firm operates in one segment, that is, the provision of cybersecurity services. The company operates and generates its revenue from UK.